The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2026

Filed:

Jul. 15, 2020
Applicant:

Regents of the University of Minnesota, Minneapolis, MN (US);

Inventors:

Jaime F. Modiano, Minneapolis, MN (US);

Taylor A. Depauw, Minnetonka, MN (US);

Ali Khammanivong, Roseville, MN (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/575 (2026.01); G16H 50/20 (2018.01);
U.S. Cl.
CPC ...
G01N 33/57557 (2026.01); G01N 33/57585 (2026.01); G16H 50/20 (2018.01); G01N 2333/70585 (2013.01); G01N 2333/70589 (2013.01); G01N 2333/70596 (2013.01); G01N 2800/60 (2013.01); G01N 2800/7014 (2013.01);
Abstract

Systems, devices, and techniques are described for characterizing subjects, such as dogs or humans, into risk categories using a blood test. For example, a method includes marking a plurality of cells from a blood sample of a subject with antibodies that recognize a plurality of markers comprising at least two of αvβ-integrin, hematopoietic progenitor marker CD34, hematopoietic progenitor marker CD117, hyaluronic acid receptor CD44, or panleukocyte marker CD45 and obtaining, based on expression of the plurality of markers in the plurality of cells, a plurality of data features for the plurality of cells. The method may also include applying a plurality of trained analytical models to a subset of the plurality of data features and generating, based on the trained analytical models, one classification for the blood sample, wherein the classification is selected from at least a high risk of HSA and a low risk of HSA.


Find Patent Forward Citations

Loading…